Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. - Fehse,F.; Trautmann,M.; Holst,JJ.; Halseth,AE.; Nanayakkara,N.; Nielsen,LL.; Fineman,MS.; Kim,DD.; Nauck,MA. (J Clin Endocrinol Metab, 2005)